4Filed Aug 6, 8:00 PM ET

Natera (NTRA) Co-Founder & Director Sheena Jonathan Sells 9,150 Shares

$NTRA · Natera, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Natera (NTRA) Co-Founder & Director Sheena Jonathan Sells 9,150 Shares

What Happened
Sheena Jonathan, a co‑founder and director of Natera (NTRA), sold a total of 9,150 shares in open‑market/private transactions on August 7, 2026, generating approximately $2,888,326 in proceeds. The sales were completed across multiple executions at prices from $308.40 to $320.90 per share (weighted average prices reported for several lots); the single largest block was 5,111 shares at a reported weighted average price of $316.61 (≈ $1.62M). These were sales (not purchases) and were effected pursuant to a preexisting Rule 10b5‑1 trading plan.

Key Details

  • Transaction date: August 7, 2026 (filed the same day — appears timely).
  • Total shares sold: 9,150; total proceeds: ≈ $2,888,326.
  • Individual reported trades:
    • 100 sh @ $308.40 = $30,840
    • 400 sh @ $310.23 = $124,090 (weighted avg; multiple prices between $309.9250–$310.5250)
    • 400 sh @ $311.88 = $124,752 (weighted avg; multiple prices between $311.5050–$312.5000)
    • 900 sh @ $313.07 = $281,760 (weighted avg; multiple prices between $312.5950–$313.3150)
    • 850 sh @ $314.25 = $267,114 (weighted avg; multiple prices between $313.9500–$314.7150)
    • 600 sh @ $315.32 = $189,191 (weighted avg; multiple prices between $315.04–$315.67)
    • 5,111 sh @ $316.61 = $1,618,203 (weighted avg; multiple prices between $316.10–$316.78)
    • 200 sh @ $317.96 = $63,593 (weighted avg; multiple prices between $317.62–$318.31)
    • 100 sh @ $318.63 = $31,863
    • 489 sh @ $320.90 = $156,920
  • Notable footnotes:
    • The sales were effected under a Rule 10b5‑1 trading plan adopted Dec 12, 2025 (preplanned trading; footnote F1).
    • Several reported prices are weighted averages covering small price ranges; full per‑execution details are available upon request (F2–F8).
    • One holding is noted as held for beneficiaries of a trust; the reporting person disclaims beneficial ownership over those trust securities (F9).
  • Shares owned after the transactions: not specified in the provided filing excerpt.

Context
Sales made under a Rule 10b5‑1 plan are typically prearranged and do not on their own indicate a change in the insider’s view of the company. For retail investors, purchases by insiders tend to be more informative about confidence in future performance; routine, preplanned sales are common for tax diversification or liquidity. This filing documents sales only and does not indicate derivative exercises, gifts, or other forms of acquisition.